111 logo
111
YI | NASDAQ
Chart Builder DCF Calculator
$2.78
-$0.06 (-2.11%)
At close: Nov 16, 2026, 3:59 PM ET
$2.78
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

111 Company Profile

Company profile explained

Company Profile

Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.

Key Executives

Name Position
Junling Liu Co-Founder, Acting Chief Financial Officer, Chairman & Chief Executive Officer
Alex Liu Finance Director
Anfeng Guo Chief Innovation Officer
Gang Yu Co-Founder & Executive Chairman
Monica Mu IR Director

Latest SEC Filings

Date Type Title
Oct 26, 2026 6-K Filing
Sep 29, 2026 4 Filing
Sep 28, 2026 6-K Filing
Sep 24, 2026 4 Filing
Sep 17, 2026 SC 13D Filing
Sep 17, 2026 6-K Filing
Sep 17, 2026 6-K Filing
Jun 16, 2026 4 Filing
Jun 16, 2026 4 Filing
Jun 12, 2026 4 Filing
View All SEC Filings ➞
111
111 logo
Country China
IPO Date Sep 12, 2018
Industry Medical - Distribution
Sector Healthcare
Employees 1,063
CEO Junling Liu

Contact Details

No.295 ZuChongZhi Road Shanghai, SH 201203 China

Stock Details

Ticker Symbol YI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001738906
CUSIP Number 68247Q201
ISIN Number US68247Q2012
SIC Code 5912

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.